Frequencies for first 10,000 rows of indi_pt variable in indi2006q3 dataset : 'Preferred Term'-level medical | terminology describing the Indication | for use | Freq. Percent Cum. ----------------------------------------+----------------------------------- ABDOMINAL DISCOMFORT | 1 0.01 0.01 ABDOMINAL HERNIA | 1 0.01 0.02 ABDOMINAL INFECTION | 1 0.01 0.03 ABDOMINAL PAIN | 5 0.05 0.08 ABDOMINAL PAIN UPPER | 5 0.05 0.13 ABNORMAL BEHAVIOUR | 2 0.02 0.15 ABSCESS | 3 0.03 0.18 ACARODERMATITIS | 5 0.05 0.23 ACCIDENTAL DRUG INTAKE BY CHILD | 1 0.01 0.24 ACCIDENTAL EXPOSURE | 3 0.03 0.27 ACINETOBACTER BACTERAEMIA | 1 0.01 0.28 ACNE | 80 0.80 1.08 ACNE CYSTIC | 1 0.01 1.09 ACQUIRED IMMUNODEFICIENCY SYNDROME | 20 0.20 1.29 ACTINIC KERATOSIS | 1 0.01 1.30 ACUTE CORONARY SYNDROME | 2 0.02 1.32 ACUTE HIV INFECTION | 1 0.01 1.33 ACUTE LYMPHOCYTIC LEUKAEMIA | 7 0.07 1.40 ACUTE MYELOID LEUKAEMIA | 35 0.35 1.75 ACUTE MYELOID LEUKAEMIA RECURRENT | 2 0.02 1.77 ACUTE MYOCARDIAL INFARCTION | 29 0.29 2.06 ACUTE PROMYELOCYTIC LEUKAEMIA | 27 0.27 2.33 ACUTE PSYCHOSIS | 2 0.02 2.35 ACUTE SINUSITIS | 3 0.03 2.38 ACUTE TONSILLITIS | 3 0.03 2.41 ADENOCARCINOMA | 2 0.02 2.43 ADENOCARCINOMA PANCREAS | 3 0.03 2.46 ADENOID CYSTIC CARCINOMA | 1 0.01 2.47 ADVERSE DRUG REACTION | 1 0.01 2.48 AFFECT LABILITY | 1 0.01 2.49 AFFECTIVE DISORDER | 8 0.08 2.57 AGITATION | 8 0.08 2.65 ALCOHOL POISONING | 2 0.02 2.67 ALCOHOL WITHDRAWAL SYNDROME | 4 0.04 2.71 ALCOHOLISM | 3 0.03 2.74 ALLERGENIC DESENSITISATION PROCEDURE | 2 0.02 2.76 ALLERGIC SINUSITIS | 1 0.01 2.77 ALOPECIA | 3 0.03 2.80 ALOPECIA AREATA | 1 0.01 2.81 ALPORT'S SYNDROME | 1 0.01 2.82 ALVEOLITIS | 1 0.01 2.83 ALVEOLITIS ALLERGIC | 1 0.01 2.84 AMNESIA | 9 0.09 2.93 AMYOTROPHIC LATERAL SCLEROSIS | 1 0.01 2.94 ANAEMIA | 27 0.27 3.21 ANAEMIA OF MALIGNANT DISEASE | 5 0.05 3.26 ANAEMIA PROPHYLAXIS | 1 0.01 3.27 ANAESTHESIA | 23 0.23 3.50 ANAESTHETIC PREMEDICATION | 3 0.03 3.53 ANALGESIC EFFECT | 10 0.10 3.63 ANALGESIC THERAPY | 8 0.08 3.71 ANAPHYLACTIC REACTION | 1 0.01 3.72 ANEURYSM | 1 0.01 3.73 ANGINA PECTORIS | 49 0.49 4.22 ANGINA UNSTABLE | 2 0.02 4.24 ANGIOGRAM | 1 0.01 4.25 ANGIOGRAM CEREBRAL | 1 0.01 4.26 ANGIOGRAM PULMONARY ABNORMAL | 1 0.01 4.27 ANGIOPATHY | 4 0.04 4.31 ANGIOPLASTY | 2 0.02 4.33 ANKLE FRACTURE | 1 0.01 4.34 ANKYLOSING SPONDYLITIS | 43 0.43 4.77 ANOGENITAL WARTS | 1 0.01 4.78 ANOREXIA | 3 0.03 4.81 ANOREXIA NERVOSA | 1 0.01 4.82 ANTACID THERAPY | 2 0.02 4.84 ANTI-INFECTIVE THERAPY | 3 0.03 4.87 ANTIBIOTIC PROPHYLAXIS | 23 0.23 5.10 ANTICOAGULANT THERAPY | 10 0.10 5.20 ANTIDEPRESSANT THERAPY | 11 0.11 5.31 ANTIEMETIC SUPPORTIVE CARE | 2 0.02 5.33 ANTIFUNGAL PROPHYLAXIS | 4 0.04 5.37 ANTIPLATELET THERAPY | 6 0.06 5.43 ANTIVIRAL PROPHYLAXIS | 18 0.18 5.61 ANXIETY | 69 0.69 6.30 ANXIETY DISORDER | 7 0.07 6.37 AORTIC ANEURYSM RUPTURE | 1 0.01 6.38 AORTIC VALVE REPAIR | 1 0.01 6.39 AORTIC VALVE REPLACEMENT | 6 0.06 6.45 APLASTIC ANAEMIA | 1 0.01 6.46 APPENDICECTOMY | 2 0.02 6.48 ARRHYTHMIA | 11 0.11 6.59 ARTERIOGRAM CORONARY | 1 0.01 6.60 ARTERIOSCLEROSIS | 1 0.01 6.61 ARTERIOSCLEROSIS CORONARY ARTERY | 2 0.02 6.63 ARTERIOSCLEROSIS OBLITERANS | 5 0.05 6.68 ARTERIOVENOUS FISTULA | 1 0.01 6.69 ARTHRALGIA | 29 0.29 6.98 ARTHRITIS | 27 0.27 7.25 ARTHRITIS INFECTIVE | 1 0.01 7.26 ASCITES | 3 0.03 7.29 ASPERGER'S DISORDER | 1 0.01 7.30 ASPERGILLOSIS | 3 0.03 7.33 ASSISTED FERTILISATION | 2 0.02 7.35 ASTHENIA | 1 0.01 7.36 ASTHMA | 98 0.98 8.34 ASTROCYTOMA | 2 0.02 8.36 ASYMPTOMATIC HIV INFECTION | 2 0.02 8.38 ATRIAL FIBRILLATION | 36 0.36 8.74 ATRIAL FLUTTER | 6 0.06 8.80 ATROPHIC VULVOVAGINITIS | 1 0.01 8.81 ATTENTION DEFICIT/HYPERACTIVITY DISOR.. | 33 0.33 9.14 AUTOIMMUNE DISORDER | 1 0.01 9.15 AUTOIMMUNE HEPATITIS | 2 0.02 9.17 B-CELL LYMPHOMA | 6 0.06 9.23 BABESIOSIS | 2 0.02 9.25 BACK PAIN | 50 0.50 9.75 BACTERAEMIA | 4 0.04 9.79 BACTERIAL INFECTION | 7 0.07 9.86 BARRETT'S OESOPHAGUS | 6 0.06 9.92 BASEDOW'S DISEASE | 5 0.05 9.97 BEHCET'S SYNDROME | 5 0.05 10.02 BENIGN PROSTATIC HYPERPLASIA | 13 0.13 10.15 BILE DUCT OBSTRUCTION | 1 0.01 10.16 BILIARY CIRRHOSIS PRIMARY | 1 0.01 10.17 BIPOLAR DISORDER | 56 0.56 10.73 BIPOLAR I DISORDER | 16 0.16 10.89 BLADDER CANCER | 10 0.10 10.99 BLADDER CANCER RECURRENT | 1 0.01 11.00 BLASTOMYCOSIS | 1 0.01 11.01 BLOOD CALCIUM | 1 0.01 11.02 BLOOD CALCIUM DECREASED | 1 0.01 11.03 BLOOD CALCIUM INCREASED | 1 0.01 11.04 BLOOD CHOLESTEROL | 8 0.08 11.12 BLOOD CHOLESTEROL DECREASED | 1 0.01 11.13 BLOOD CHOLESTEROL INCREASED | 41 0.41 11.54 BLOOD GLUCOSE | 1 0.01 11.55 BLOOD GLUCOSE INCREASED | 1 0.01 11.56 BLOOD GROWTH HORMONE DECREASED | 1 0.01 11.57 BLOOD IRON DECREASED | 1 0.01 11.58 BLOOD IRON INCREASED | 15 0.15 11.73 BLOOD POTASSIUM | 1 0.01 11.74 BLOOD PRESSURE | 6 0.06 11.80 BLOOD PRESSURE INCREASED | 5 0.05 11.85 BLOOD PRESSURE MANAGEMENT | 2 0.02 11.87 BLOOD TRIGLYCERIDES ABNORMAL | 1 0.01 11.88 BLOOD TRIGLYCERIDES INCREASED | 3 0.03 11.91 BLOOD UREA INCREASED | 1 0.01 11.92 BODY HEIGHT BELOW NORMAL | 1 0.01 11.93 BONE DENSITOMETRY | 1 0.01 11.94 BONE MARROW CONDITIONING REGIMEN | 15 0.15 12.09 BONE MARROW TRANSPLANT | 2 0.02 12.11 BONE PAIN | 2 0.02 12.13 BONE SARCOMA | 1 0.01 12.14 BONE TUBERCULOSIS | 2 0.02 12.16 BORDERLINE PERSONALITY DISORDER | 1 0.01 12.17 BRAIN OEDEMA | 1 0.01 12.18 BREAKTHROUGH PAIN | 5 0.05 12.23 BREAST CANCER | 108 1.08 13.31 BREAST CANCER FEMALE | 9 0.09 13.40 BREAST CANCER IN SITU | 1 0.01 13.41 BREAST CANCER METASTATIC | 21 0.21 13.62 BREAST CANCER RECURRENT | 1 0.01 13.63 BREAST CANCER STAGE IV | 1 0.01 13.64 BRONCHIAL CARCINOMA | 7 0.07 13.71 BRONCHIAL DISORDER | 3 0.03 13.74 BRONCHIAL HYPERREACTIVITY | 2 0.02 13.76 BRONCHIECTASIS | 2 0.02 13.78 BRONCHIOLITIS | 1 0.01 13.79 BRONCHITIS | 28 0.28 14.07 BRONCHITIS ACUTE | 16 0.16 14.23 BRONCHOPNEUMONIA | 1 0.01 14.24 BRONCHOPULMONARY ASPERGILLOSIS | 3 0.03 14.27 BRONCHOSCOPY | 1 0.01 14.28 BRUXISM | 1 0.01 14.29 C-REACTIVE PROTEIN INCREASED | 2 0.02 14.31 CACHEXIA | 1 0.01 14.32 CAESAREAN SECTION | 4 0.04 14.36 CALCULUS URETERIC | 2 0.02 14.38 CANCER PAIN | 12 0.12 14.50 CANDIDIASIS | 7 0.07 14.57 CARCINOID SYNDROME | 1 0.01 14.58 CARCINOID TUMOUR | 1 0.01 14.59 CARCINOMA IN SITU OF BLADDER | 3 0.03 14.62 CARDIAC ASTHMA | 3 0.03 14.65 CARDIAC DISORDER | 4 0.04 14.69 CARDIAC FAILURE | 33 0.33 15.02 CARDIAC FAILURE CONGESTIVE | 9 0.09 15.11 CARDIAC STRESS TEST | 1 0.01 15.12 CARDIOMYOPATHY | 1 0.01 15.13 CARDIOVASCULAR DISORDER | 2 0.02 15.15 CARDIOVASCULAR EVENT PROPHYLAXIS | 4 0.04 15.19 CAROTID ARTERY STENOSIS | 2 0.02 15.21 CARPAL TUNNEL SYNDROME | 2 0.02 15.23 CATARACT | 2 0.02 15.25 CATARACT OPERATION | 10 0.10 15.35 CATHETER RELATED INFECTION | 1 0.01 15.36 CATHETERISATION CARDIAC | 2 0.02 15.38 CELLULITIS | 9 0.09 15.47 CEREBRAL HAEMORRHAGE | 3 0.03 15.50 CEREBRAL INFARCTION | 6 0.06 15.56 CEREBRAL TOXOPLASMOSIS | 5 0.05 15.61 CEREBROVASCULAR ACCIDENT | 9 0.09 15.70 CEREBROVASCULAR ACCIDENT PROPHYLAXIS | 6 0.06 15.76 CEREBROVASCULAR DISORDER | 3 0.03 15.79 CERVICAL MYELOPATHY | 1 0.01 15.80 CERVICOBRACHIAL SYNDROME | 1 0.01 15.81 CERVIX CARCINOMA | 1 0.01 15.82 CERVIX OPERATION | 1 0.01 15.83 CHEMOTHERAPY | 6 0.06 15.89 CHEST DISCOMFORT | 2 0.02 15.91 CHEST PAIN | 4 0.04 15.95 CHLOROMA | 1 0.01 15.96 CHOLECYSTITIS | 2 0.02 15.98 CHOLELITHIASIS | 2 0.02 16.00 CHONDROCALCINOSIS | 1 0.01 16.01 CHRONIC INFLAMMATORY DEMYELINATING PO.. | 1 0.01 16.02 CHRONIC LYMPHOCYTIC LEUKAEMIA | 15 0.15 16.17 CHRONIC MYELOID LEUKAEMIA | 21 0.21 16.38 CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 59 0.59 16.97 CHRONIC RESPIRATORY FAILURE | 1 0.01 16.98 CHRONIC SINUSITIS | 1 0.01 16.99 CLEAR CELL CARCINOMA OF THE KIDNEY | 1 0.01 17.00 CLUSTER HEADACHE | 2 0.02 17.02 COGNITIVE DISORDER | 1 0.01 17.03 COLITIS | 4 0.04 17.07 COLITIS ULCERATIVE | 8 0.08 17.15 COLON CANCER | 52 0.52 17.67 COLON CANCER METASTATIC | 12 0.12 17.79 COLONOSCOPY | 1 0.01 17.80 COLONY STIMULATING FACTOR PROPHYLAXIS | 3 0.03 17.83 COLORECTAL CANCER | 27 0.27 18.10 COLORECTAL CANCER METASTATIC | 61 0.61 18.71 COLORECTAL CANCER STAGE III | 3 0.03 18.74 COMPLETED SUICIDE | 3 0.03 18.77 COMPRESSION FRACTURE | 2 0.02 18.79 COMPUTERISED TOMOGRAM ABDOMEN | 9 0.09 18.88 COMPUTERISED TOMOGRAM THORAX | 1 0.01 18.89 CONDUCT DISORDER | 1 0.01 18.90 CONFUSIONAL STATE | 4 0.04 18.94 CONGENITAL TOXOPLASMOSIS | 1 0.01 18.95 CONJUNCTIVITIS ALLERGIC | 3 0.03 18.98 CONSTIPATION | 28 0.28 19.26 CONTRACEPTION | 27 0.27 19.53 CONVULSION | 49 0.49 20.02 CONVULSION PROPHYLAXIS | 10 0.10 20.12 CORD BLOOD TRANSPLANT THERAPY | 2 0.02 20.14 CORNEAL TRANSPLANT | 1 0.01 20.15 CORONARY ANGIOPLASTY | 4 0.04 20.19 CORONARY ARTERIAL STENT INSERTION | 5 0.05 20.24 CORONARY ARTERY BYPASS | 5 0.05 20.29 CORONARY ARTERY DISEASE | 20 0.20 20.49 COUGH | 19 0.19 20.68 CROHN'S DISEASE | 87 0.87 21.55 CRYPTOCOCCOSIS | 2 0.02 21.57 CUTANEOUS LEISHMANIASIS | 1 0.01 21.58 CYSTITIS | 9 0.09 21.67 CYSTITIS INTERSTITIAL | 2 0.02 21.69 CYTOMEGALOVIRUS CHORIORETINITIS | 2 0.02 21.71 CYTOMEGALOVIRUS INFECTION | 2 0.02 21.73 DEEP VEIN THROMBOSIS | 8 0.08 21.81 DEHYDRATION | 3 0.03 21.84 DELUSIONAL DISORDER, PERSECUTORY TYPE | 1 0.01 21.85 DEMENTIA | 9 0.09 21.94 DEMENTIA ALZHEIMER'S TYPE | 14 0.14 22.08 DEMYELINATION | 2 0.02 22.10 DENTAL DISORDER PROPHYLAXIS | 1 0.01 22.11 DEPENDENCE | 1 0.01 22.12 DEPRESSED MOOD | 1 0.01 22.13 DEPRESSION | 227 2.27 24.40 DEPRESSION POSTMENOPAUSAL | 12 0.12 24.52 DERMATITIS | 1 0.01 24.53 DERMATITIS ATOPIC | 9 0.09 24.62 DERMATITIS CONTACT | 1 0.01 24.63 DERMATITIS EXFOLIATIVE | 3 0.03 24.66 DERMATOMYOSITIS | 1 0.01 24.67 DERMATOSIS | 1 0.01 24.68 DEVICE RELATED INFECTION | 3 0.03 24.71 DIABETES MELLITUS | 136 1.36 26.07 DIABETES MELLITUS INADEQUATE CONTROL | 1 0.01 26.08 DIABETES MELLITUS INSULIN-DEPENDENT | 51 0.51 26.59 DIABETES MELLITUS MANAGEMENT | 2 0.02 26.61 DIABETES MELLITUS NON-INSULIN-DEPENDENT | 107 1.07 27.68 DIABETIC NEPHROPATHY | 3 0.03 27.71 DIABETIC NEUROPATHY | 4 0.04 27.75 DIAGNOSTIC PROCEDURE | 2 0.02 27.77 DIALYSIS | 4 0.04 27.81 DIARRHOEA | 6 0.06 27.87 DIARRHOEA HAEMORRHAGIC | 2 0.02 27.89 DISCOGRAM ABNORMAL | 2 0.02 27.91 DISEASE RECURRENCE | 5 0.05 27.96 DISSEMINATED INTRAVASCULAR COAGULATION | 7 0.07 28.03 DISTURBANCE IN ATTENTION | 1 0.01 28.04 DIURETIC EFFECT | 1 0.01 28.05 DIURETIC THERAPY | 8 0.08 28.13 DIVERTICULITIS | 2 0.02 28.15 DIVORCED | 1 0.01 28.16 DIZZINESS | 3 0.03 28.19 DRUG ADMINISTRATION ERROR | 4 0.04 28.23 DRUG DEPENDENCE | 5 0.05 28.28 DRUG DETOXIFICATION | 1 0.01 28.29 DRUG ERUPTION | 1 0.01 28.30 DRUG EXPOSURE DURING PREGNANCY | 44 0.44 28.74 DRUG HYPERSENSITIVITY | 1 0.01 28.75 DRUG THERAPY | 1 0.01 28.76 DRUG USE FOR UNKNOWN INDICATION | 984 9.84 38.60 DRUG WITHDRAWAL MAINTENANCE THERAPY | 1 0.01 38.61 DRUG WITHDRAWAL SYNDROME | 5 0.05 38.66 DRY EYE | 1 0.01 38.67 DUODENAL ULCER | 2 0.02 38.69 DUODENAL ULCER HAEMORRHAGE | 1 0.01 38.70 DYSGEUSIA | 1 0.01 38.71 DYSLIPIDAEMIA | 14 0.14 38.85 DYSMENORRHOEA | 2 0.02 38.87 DYSPEPSIA | 16 0.16 39.03 DYSPHAGIA | 1 0.01 39.04 DYSPNOEA | 7 0.07 39.11 DYSTHYMIC DISORDER | 8 0.08 39.19 DYSTONIA | 1 0.01 39.20 EAR DISORDER | 1 0.01 39.21 EAR INFECTION | 6 0.06 39.27 EATING DISORDER | 1 0.01 39.28 ECTOPIC PREGNANCY | 1 0.01 39.29 ECZEMA | 10 0.10 39.39 EMBOLISM | 1 0.01 39.40 EMPHYSEMA | 4 0.04 39.44 EMPTY SELLA SYNDROME | 1 0.01 39.45 ENCEPHALITIS | 2 0.02 39.47 ENCEPHALITIS HERPES | 1 0.01 39.48 ENDOCARDITIS | 1 0.01 39.49 ENDOCRINE TEST | 1 0.01 39.50 ENDOMETRIOSIS | 3 0.03 39.53 ENTERITIS | 1 0.01 39.54 ENTEROBIASIS | 2 0.02 39.56 ENTEROCOCCAL BACTERAEMIA | 1 0.01 39.57 ENTEROCOCCAL INFECTION | 1 0.01 39.58 ENTEROCOLITIS | 5 0.05 39.63 ENURESIS | 2 0.02 39.65 EPIDIDYMITIS | 1 0.01 39.66 EPIDURAL ANAESTHESIA | 6 0.06 39.72 EPILEPSY | 88 0.88 40.60 ERECTILE DYSFUNCTION | 15 0.15 40.75 EROSIVE DUODENITIS | 1 0.01 40.76 ERYSIPELAS | 7 0.07 40.83 ERYTHRODERMIC PSORIASIS | 1 0.01 40.84 ESCHERICHIA INFECTION | 1 0.01 40.85 ESCHERICHIA SEPSIS | 1 0.01 40.86 ESCHERICHIA URINARY TRACT INFECTION | 1 0.01 40.87 ESCHERICHIA VAGINITIS | 1 0.01 40.88 ESSENTIAL HYPERTENSION | 15 0.15 41.03 ESSENTIAL TREMOR | 1 0.01 41.04 EUPHORIC MOOD | 1 0.01 41.05 EUSTACHIAN TUBE DYSFUNCTION | 1 0.01 41.06 EXTRADURAL ABSCESS | 4 0.04 41.10 EXTRAPYRAMIDAL DISORDER | 2 0.02 41.12 EXTRASYSTOLES | 1 0.01 41.13 EYE IRRIGATION | 10 0.10 41.23 EYE OPERATION | 9 0.09 41.32 EYE PRURITUS | 1 0.01 41.33 FABRY'S DISEASE | 1 0.01 41.34 FACIAL NERVE DISORDER | 1 0.01 41.35 FACIAL NEURALGIA | 2 0.02 41.37 FACIAL PALSY | 1 0.01 41.38 FACTOR V LEIDEN MUTATION | 1 0.01 41.39 FACTOR VIII DEFICIENCY | 9 0.09 41.48 FAECAL INCONTINENCE | 1 0.01 41.49 FASCIITIS | 2 0.02 41.51 FATIGUE | 1 0.01 41.52 FEBRILE INFECTION | 1 0.01 41.53 FEBRILE NEUTROPENIA | 1 0.01 41.54 FEMUR FRACTURE | 1 0.01 41.55 FIBROMYALGIA | 6 0.06 41.61 FISTULA | 1 0.01 41.62 FLANK PAIN | 2 0.02 41.64 FLUID REPLACEMENT | 1 0.01 41.65 FLUID RETENTION | 5 0.05 41.70 FLUSHING | 1 0.01 41.71 FOLATE DEFICIENCY | 1 0.01 41.72 FOOD ALLERGY | 1 0.01 41.73 FRACTURE | 1 0.01 41.74 FUNGAEMIA | 1 0.01 41.75 FUNGAL INFECTION | 3 0.03 41.78 FUNGAL RASH | 1 0.01 41.79 FUNGAL SKIN INFECTION | 1 0.01 41.80 FURUNCLE | 2 0.02 41.82 GALLBLADDER CANCER | 1 0.01 41.83 GASTRIC ATONY | 1 0.01 41.84 GASTRIC CANCER | 13 0.13 41.97 GASTRIC CANCER RECURRENT | 6 0.06 42.03 GASTRIC DISORDER | 3 0.03 42.06 GASTRIC ULCER | 15 0.15 42.21 GASTRIC ULCER HELICOBACTER | 3 0.03 42.24 GASTRITIS | 35 0.35 42.59 GASTROENTERITIS | 5 0.05 42.64 GASTROINTESTINAL CARCINOMA | 1 0.01 42.65 GASTROINTESTINAL DISORDER | 11 0.11 42.76 GASTROINTESTINAL DISORDER THERAPY | 1 0.01 42.77 GASTROINTESTINAL ENDOSCOPIC THERAPY | 1 0.01 42.78 GASTROINTESTINAL MOTILITY DISORDER | 1 0.01 42.79 GASTROINTESTINAL PAIN | 1 0.01 42.80 GASTROINTESTINAL STROMAL TUMOUR | 9 0.09 42.89 GASTROOESOPHAGEAL CANCER | 3 0.03 42.92 GASTROOESOPHAGEAL REFLUX DISEASE | 23 0.23 43.15 GAUCHER'S DISEASE | 7 0.07 43.22 GENERAL ANAESTHESIA | 7 0.07 43.29 GENERALISED ANXIETY DISORDER | 2 0.02 43.31 GENITAL PAIN FEMALE | 1 0.01 43.32 GESTATIONAL DIABETES | 2 0.02 43.34 GINGIVAL PAIN | 1 0.01 43.35 GINGIVITIS | 1 0.01 43.36 GLAUCOMA | 3 0.03 43.39 GLIOBLASTOMA | 6 0.06 43.45 GLIOBLASTOMA MULTIFORME | 12 0.12 43.57 GLIOMA | 1 0.01 43.58 GLOBULINURIA | 1 0.01 43.59 GLUCAGON TOLERANCE TEST | 1 0.01 43.60 GLYCOGEN STORAGE DISEASE TYPE II | 1 0.01 43.61 GOITRE | 1 0.01 43.62 GOODPASTURE'S SYNDROME | 1 0.01 43.63 GOUT | 11 0.11 43.74 GRAFT VERSUS HOST DISEASE | 1 0.01 43.75 GRAND MAL CONVULSION | 2 0.02 43.77 GRANULOMA SKIN | 3 0.03 43.80 GROWTH HORMONE DEFICIENCY | 6 0.06 43.86 HAEMATURIA | 1 0.01 43.87 HAEMOCHROMATOSIS | 1 0.01 43.88 HAEMODIALYSIS | 1 0.01 43.89 HAEMORRHAGE | 3 0.03 43.92 HAEMOSIDEROSIS | 1 0.01 43.93 HALLUCINATION | 3 0.03 43.96 HALLUCINATION, AUDITORY | 2 0.02 43.98 HEADACHE | 31 0.31 44.29 HEART RATE IRREGULAR | 1 0.01 44.30 HEART TRANSPLANT | 4 0.04 44.34 HEART VALVE REPLACEMENT | 1 0.01 44.35 HELICOBACTER INFECTION | 19 0.19 44.54 HEPATIC CIRRHOSIS | 9 0.09 44.63 HEPATIC FUNCTION ABNORMAL | 1 0.01 44.64 HEPATIC NEOPLASM MALIGNANT | 8 0.08 44.72 HEPATITIS | 3 0.03 44.75 HEPATITIS B | 14 0.14 44.89 HEPATITIS C | 143 1.43 46.32 HERNIA | 2 0.02 46.34 HERPES SIMPLEX | 1 0.01 46.35 HERPES VIRUS INFECTION | 2 0.02 46.37 HERPES ZOSTER | 44 0.44 46.81 HIATUS HERNIA | 1 0.01 46.82 HIV INFECTION | 418 4.18 51.00 HODGKIN'S DISEASE | 4 0.04 51.04 HORMONE REPLACEMENT THERAPY | 141 1.41 52.45 HORMONE THERAPY | 3 0.03 52.48 HOT FLUSH | 1 0.01 52.49 HOUSE DUST ALLERGY | 3 0.03 52.52 HUMAN HERPESVIRUS 6 INFECTION | 1 0.01 52.53 HUMAN IMMUNODEFICIENCY VIRUS TRANSMIS.. | 15 0.15 52.68 HYPERCALCAEMIA | 1 0.01 52.69 HYPERCALCAEMIA OF MALIGNANCY | 1 0.01 52.70 HYPERCHLORHYDRIA | 2 0.02 52.72 HYPERCHOLESTEROLAEMIA | 60 0.60 53.32 HYPERGLYCAEMIA | 2 0.02 53.34 HYPERKINETIC HEART SYNDROME | 1 0.01 53.35 HYPERLIPIDAEMIA | 42 0.42 53.77 HYPERPARATHYROIDISM | 1 0.01 53.78 HYPERPARATHYROIDISM SECONDARY | 7 0.07 53.85 HYPERPHOSPHATAEMIA | 6 0.06 53.91 HYPERSENSITIVITY | 9 0.09 54.00 HYPERTENSION | 437 4.37 58.37 HYPERTENSIVE HEART DISEASE | 5 0.05 58.42 HYPERTHYROIDISM | 2 0.02 58.44 HYPERTONIA | 2 0.02 58.46 HYPERTONIC BLADDER | 6 0.06 58.52 HYPERTRIGLYCERIDAEMIA | 3 0.03 58.55 HYPERTROPHIC CARDIOMYOPATHY | 3 0.03 58.58 HYPERURICAEMIA | 9 0.09 58.67 HYPERVENTILATION | 2 0.02 58.69 HYPOAESTHESIA | 2 0.02 58.71 HYPOGAMMAGLOBULINAEMIA | 2 0.02 58.73 HYPOKALAEMIA | 1 0.01 58.74 HYPOMAGNESAEMIA | 1 0.01 58.75 HYPOPHOSPHATAEMIA | 1 0.01 58.76 HYPOPITUITARISM | 4 0.04 58.80 HYPOTENSION | 1 0.01 58.81 HYPOTHYROIDISM | 33 0.33 59.14 HYPOTONIA | 3 0.03 59.17 HYSTERECTOMY | 1 0.01 59.18 IDIOPATHIC PULMONARY FIBROSIS | 2 0.02 59.20 IDIOPATHIC THROMBOCYTOPENIC PURPURA | 2 0.02 59.22 ILL-DEFINED DISORDER | 68 0.68 59.90 IMMUNISATION | 3 0.03 59.93 IMMUNODEFICIENCY | 1 0.01 59.94 IMMUNOSUPPRESSANT DRUG THERAPY | 1 0.01 59.95 IMMUNOSUPPRESSION | 4 0.04 59.99 IMPAIRED GASTRIC EMPTYING | 2 0.02 60.01 INCONTINENCE | 2 0.02 60.03 INCREASED VENTRICULAR AFTERLOAD | 1 0.01 60.04 INDUCTION OF ANAESTHESIA | 19 0.19 60.23 INDURATION | 1 0.01 60.24 INFECTION | 27 0.27 60.51 INFECTION PROPHYLAXIS | 13 0.13 60.64 INFERTILITY FEMALE | 1 0.01 60.65 INFLAMMATION | 9 0.09 60.74 INFLAMMATORY BOWEL DISEASE | 2 0.02 60.76 INFLUENZA | 2 0.02 60.78 INITIAL INSOMNIA | 1 0.01 60.79 INJECTION SITE ABSCESS | 1 0.01 60.80 INSOMNIA | 75 0.75 61.55 INSULIN RESISTANCE | 1 0.01 61.56 INSULIN-REQUIRING TYPE II DIABETES ME.. | 29 0.29 61.85 INTENTIONAL DRUG MISUSE | 3 0.03 61.88 INTERFERON GAMMA RECEPTOR DEFICIENCY | 1 0.01 61.89 INTERMITTENT EXPLOSIVE DISORDER | 3 0.03 61.92 INTERSTITIAL LUNG DISEASE | 1 0.01 61.93 INTERVERTEBRAL DISC DEGENERATION | 1 0.01 61.94 INTERVERTEBRAL DISC DISORDER | 1 0.01 61.95 INTESTINAL FUNCTIONAL DISORDER | 1 0.01 61.96 INTESTINAL OBSTRUCTION | 6 0.06 62.02 INTRAOCULAR PRESSURE INCREASED | 1 0.01 62.03 INTRAVENOUS CATHETER MANAGEMENT | 1 0.01 62.04 IRON DEFICIENCY | 1 0.01 62.05 IRON DEFICIENCY ANAEMIA | 4 0.04 62.09 IRON METABOLISM DISORDER | 1 0.01 62.10 IRRITABLE BOWEL SYNDROME | 38 0.38 62.48 ISCHAEMIC CARDIOMYOPATHY | 1 0.01 62.49 ISCHAEMIC HEART DISEASE PROPHYLAXIS | 2 0.02 62.51 ISCHAEMIC STROKE | 5 0.05 62.56 JOINT DISLOCATION | 2 0.02 62.58 JUVENILE ARTHRITIS | 17 0.17 62.75 KERATITIS HERPETIC | 2 0.02 62.77 KERATOSIS FOLLICULAR | 1 0.01 62.78 KIDNEY TRANSPLANT REJECTION | 1 0.01 62.79 KNEE OPERATION | 1 0.01 62.80 LABOUR INDUCTION | 1 0.01 62.81 LABYRINTHITIS | 1 0.01 62.82 LARGE INTESTINE CARCINOMA | 5 0.05 62.87 LARYNGEAL CANCER | 1 0.01 62.88 LARYNGITIS | 2 0.02 62.90 LARYNGOTRACHEO BRONCHITIS | 4 0.04 62.94 LEIOMYOSARCOMA METASTATIC | 1 0.01 62.95 LEUKAEMIA | 1 0.01 62.96 LEUKOCYTOCLASTIC VASCULITIS | 5 0.05 63.01 LEUKOPENIA | 3 0.03 63.04 LIBIDO DISORDER | 1 0.01 63.05 LIMB INJURY | 2 0.02 63.07 LIP AND/OR ORAL CAVITY CANCER | 2 0.02 63.09 LIP AND/OR ORAL CAVITY CANCER RECURRENT | 1 0.01 63.10 LIP AND/OR ORAL CAVITY CANCER STAGE III | 3 0.03 63.13 LIPID METABOLISM DISORDER | 2 0.02 63.15 LIPIDS INCREASED | 2 0.02 63.17 LIVER ABSCESS | 1 0.01 63.18 LIVER DISORDER | 2 0.02 63.20 LIVER TRANSPLANT | 20 0.20 63.40 LOCAL ANAESTHESIA | 9 0.09 63.49 LOCAL ANTIBACTERIAL THERAPY | 1 0.01 63.50 LOCALISED INFECTION | 3 0.03 63.53 LONG QT SYNDROME CONGENITAL | 2 0.02 63.55 LOW DENSITY LIPOPROTEIN INCREASED | 2 0.02 63.57 LOWER RESPIRATORY TRACT INFECTION | 2 0.02 63.59 LUMBAR HERNIA | 1 0.01 63.60 LUNG ABSCESS | 1 0.01 63.61 LUNG ADENOCARCINOMA | 2 0.02 63.63 LUNG ADENOCARCINOMA STAGE IV | 1 0.01 63.64 LUNG CANCER METASTATIC | 2 0.02 63.66 LUNG DISORDER | 3 0.03 63.69 LUNG INFECTION | 3 0.03 63.72 LUNG INFECTION PSEUDOMONAL | 1 0.01 63.73 LUNG NEOPLASM MALIGNANT | 11 0.11 63.84 LUNG SQUAMOUS CELL CARCINOMA STAGE UN.. | 2 0.02 63.86 LYMPHADENOPATHY | 2 0.02 63.88 LYMPHOMA | 8 0.08 63.96 LYMPHOPROLIFERATIVE DISORDER | 1 0.01 63.97 MACULAR DEGENERATION | 6 0.06 64.03 MACULAR OEDEMA | 7 0.07 64.10 MAINTENANCE OF ANAESTHESIA | 14 0.14 64.24 MAJOR DEPRESSION | 19 0.19 64.43 MALAISE | 8 0.08 64.51 MALARIA | 1 0.01 64.52 MALARIA PROPHYLAXIS | 4 0.04 64.56 MALE PATTERN BALDNESS | 1 0.01 64.57 MALIGNANT GLIOMA | 4 0.04 64.61 MALIGNANT HYPERTENSION | 1 0.01 64.62 MALIGNANT MELANOMA | 1 0.01 64.63 MALIGNANT NEOPLASM OF AMPULLA OF VATER | 1 0.01 64.64 MALIGNANT NEOPLASM OF ISLETS OF LANGE.. | 4 0.04 64.68 MANIA | 1 0.01 64.69 MANTLE CELL LYMPHOMA | 6 0.06 64.75 MASTITIS | 1 0.01 64.76 MEDICAL DIET | 5 0.05 64.81 MEDICATION ERROR | 1 0.01 64.82 MEGACOLON | 1 0.01 64.83 MELAS SYNDROME | 4 0.04 64.87 MEMORY IMPAIRMENT | 1 0.01 64.88 MENIERE'S DISEASE | 1 0.01 64.89 MENINGITIS | 1 0.01 64.90 MENINGITIS CRYPTOCOCCAL | 3 0.03 64.93 MENINGITIS TUBERCULOUS | 1 0.01 64.94 MENINGOCOCCAL SEPSIS | 1 0.01 64.95 MENOPAUSAL SYMPTOMS | 13 0.13 65.08 MENOPAUSE | 1 0.01 65.09 MENORRHAGIA | 1 0.01 65.10 MENSTRUATION IRREGULAR | 2 0.02 65.12 MENTAL DISORDER | 5 0.05 65.17 MESOTHELIOMA | 3 0.03 65.20 METABOLIC DISORDER | 1 0.01 65.21 METABOLIC SYNDROME | 1 0.01 65.22 METASTASES TO BONE | 49 0.49 65.71 METASTASES TO LUNG | 2 0.02 65.73 METASTASIS | 5 0.05 65.78 METASTATIC MALIGNANT MELANOMA | 10 0.10 65.88 METASTATIC NEOPLASM | 3 0.03 65.91 METASTATIC PAIN | 12 0.12 66.03 METASTATIC RENAL CELL CARCINOMA | 29 0.29 66.32 MICTURITION DISORDER | 2 0.02 66.34 MICTURITION URGENCY | 1 0.01 66.35 MIGRAINE | 269 2.69 69.04 MIGRAINE PROPHYLAXIS | 2 0.02 69.06 MINERAL SUPPLEMENTATION | 3 0.03 69.09 MOLLUSCUM CONTAGIOSUM | 1 0.01 69.10 MONARTHRITIS | 1 0.01 69.11 MOOD ALTERED | 4 0.04 69.15 MOOD DISORDER DUE TO A GENERAL MEDICA.. | 1 0.01 69.16 MOTION SICKNESS | 2 0.02 69.18 MUCOSAL INFLAMMATION | 1 0.01 69.19 MULTIPLE ALLERGIES | 6 0.06 69.25 MULTIPLE MYELOMA | 108 1.08 70.33 MULTIPLE SCLEROSIS | 181 1.81 72.14 MUSCLE NECROSIS | 1 0.01 72.15 MUSCLE RELAXANT THERAPY | 1 0.01 72.16 MUSCLE SPASMS | 11 0.11 72.27 MUSCLE SPASTICITY | 3 0.03 72.30 MUSCULOSKELETAL PAIN | 3 0.03 72.33 MUSCULOSKELETAL STIFFNESS | 1 0.01 72.34 MYCOBACTERIUM AVIUM COMPLEX INFECTION | 2 0.02 72.36 MYCOBACTERIUM KANSASII INFECTION | 1 0.01 72.37 MYCOPLASMA INFECTION | 1 0.01 72.38 MYCOSIS FUNGOIDES | 2 0.02 72.40 MYELODYSPLASTIC SYNDROME | 25 0.25 72.65 MYOCARDIAL INFARCTION | 12 0.12 72.77 MYOCARDIAL ISCHAEMIA | 6 0.06 72.83 MYOCLONIC EPILEPSY | 2 0.02 72.85 MYOSITIS | 2 0.02 72.87 NAIL TINEA | 20 0.20 73.07 NASAL CAVITY PACKING | 1 0.01 73.08 NASAL CONGESTION | 1 0.01 73.09 NASAL POLYPS | 3 0.03 73.12 NASOPHARYNGEAL CANCER | 1 0.01 73.13 NASOPHARYNGEAL DISORDER | 1 0.01 73.14 NASOPHARYNGITIS | 10 0.10 73.24 NAUSEA | 23 0.23 73.47 NECK PAIN | 3 0.03 73.50 NEOPLASM MALIGNANT | 23 0.23 73.73 NEOPLASM PROPHYLAXIS | 1 0.01 73.74 NEPHROBLASTOMA | 12 0.12 73.86 NEPHROGENIC ANAEMIA | 1 0.01 73.87 NEPHROGENIC FIBROSING DERMOPATHY | 2 0.02 73.89 NEPHROTIC SYNDROME | 1 0.01 73.90 NERVE BLOCK | 1 0.01 73.91 NERVE INJURY | 3 0.03 73.94 NERVOUS SYSTEM DISORDER | 2 0.02 73.96 NERVOUSNESS | 4 0.04 74.00 NEURALGIA | 24 0.24 74.24 NEUROBLASTOMA | 1 0.01 74.25 NEUROBORRELIOSIS | 1 0.01 74.26 NEURODERMATITIS | 1 0.01 74.27 NEUROENDOCRINE TUMOUR | 4 0.04 74.31 NEUROGENIC BLADDER | 1 0.01 74.32 NEUROMUSCULAR BLOCKADE REVERSAL | 2 0.02 74.34 NEUROMYELITIS OPTICA | 2 0.02 74.36 NEUROPATHY | 4 0.04 74.40 NEUROPATHY PERIPHERAL | 9 0.09 74.49 NEUROSIS | 6 0.06 74.55 NEUTROPENIA | 5 0.05 74.60 NIGHT SWEATS | 2 0.02 74.62 NOCARDIOSIS | 9 0.09 74.71 NON-HODGKIN'S LYMPHOMA | 17 0.17 74.88 NON-HODGKIN'S LYMPHOMA RECURRENT | 1 0.01 74.89 NON-SMALL CELL LUNG CANCER | 76 0.76 75.65 NON-SMALL CELL LUNG CANCER STAGE III | 3 0.03 75.68 NORMAL PRESSURE HYDROCEPHALUS | 4 0.04 75.72 NUCLEAR MAGNETIC RESONANCE IMAGING | 4 0.04 75.76 NUTRITIONAL SUPPORT | 2 0.02 75.78 OBESITY | 6 0.06 75.84 OBSESSIVE-COMPULSIVE DISORDER | 11 0.11 75.95 OBSTRUCTIVE AIRWAYS DISORDER | 1 0.01 75.96 ODYNOPHAGIA | 1 0.01 75.97 OEDEMA | 11 0.11 76.08 OEDEMA PERIPHERAL | 2 0.02 76.10 OESOPHAGEAL CANDIDIASIS | 1 0.01 76.11 OESOPHAGEAL CARCINOMA | 10 0.10 76.21 OESOPHAGEAL DISORDER | 1 0.01 76.22 OESOPHAGEAL SQUAMOUS CELL CARCINOMA | 11 0.11 76.33 OESOPHAGEAL SQUAMOUS CELL CARCINOMA S.. | 1 0.01 76.34 OESOPHAGITIS | 2 0.02 76.36 OESTROGEN REPLACEMENT THERAPY | 1 0.01 76.37 OFF LABEL USE | 3 0.03 76.40 OLIGODENDROGLIOMA | 1 0.01 76.41 OPTIC NERVE HYPOPLASIA | 1 0.01 76.42 ORAL CANDIDIASIS | 2 0.02 76.44 ORAL CONTRACEPTION | 13 0.13 76.57 ORAL FUNGAL INFECTION | 1 0.01 76.58 ORAL PAIN | 1 0.01 76.59 ORAL SOFT TISSUE DISORDER | 1 0.01 76.60 ORCHITIS | 6 0.06 76.66 OROPHARYNGEAL CANCER STAGE UNSPECIFIED | 3 0.03 76.69 ORTHOSTATIC HYPOTENSION | 1 0.01 76.70 OSTEITIS DEFORMANS | 1 0.01 76.71 OSTEOARTHRITIS | 15 0.15 76.86 OSTEOMYELITIS | 5 0.05 76.91 OSTEOPENIA | 12 0.12 77.03 OSTEOPOROSIS | 132 1.32 78.35 OSTEOPOROSIS POSTMENOPAUSAL | 4 0.04 78.39 OSTEOPOROSIS PROPHYLAXIS | 1 0.01 78.40 OSTEOPOROTIC FRACTURE | 5 0.05 78.45 OTITIS MEDIA | 5 0.05 78.50 OTITIS MEDIA ACUTE | 1 0.01 78.51 OVARIAN CANCER | 26 0.26 78.77 OVARIAN EPITHELIAL CANCER | 3 0.03 78.80 OVARIAN EPITHELIAL CANCER RECURRENT | 1 0.01 78.81 OVERDOSE | 4 0.04 78.85 OXYGEN SATURATION DECREASED | 1 0.01 78.86 PAIN | 160 1.60 80.46 PAIN IN EXTREMITY | 6 0.06 80.52 PAIN IN JAW | 1 0.01 80.53 PAIN MANAGEMENT | 2 0.02 80.55 PAIN PROPHYLAXIS | 1 0.01 80.56 PANCREATIC CARCINOMA | 10 0.10 80.66 PANCREATIC CARCINOMA METASTATIC | 12 0.12 80.78 PANCREATIC NEOPLASM | 7 0.07 80.85 PANCREATITIS | 2 0.02 80.87 PANCREATITIS NECROTISING | 2 0.02 80.89 PANIC ATTACK | 4 0.04 80.93 PANIC DISORDER | 12 0.12 81.05 PAPILLARY THYROID CANCER | 1 0.01 81.06 PARAESTHESIA | 1 0.01 81.07 PARALYSIS | 1 0.01 81.08 PARANOIA | 1 0.01 81.09 PARENTERAL NUTRITION | 7 0.07 81.16 PARKINSON'S DISEASE | 57 0.57 81.73 PARKINSONIAN GAIT | 1 0.01 81.74 PARKINSONISM | 4 0.04 81.78 PARTIAL SEIZURES | 9 0.09 81.87 PATELLOFEMORAL PAIN SYNDROME | 1 0.01 81.88 PATENT DUCTUS ARTERIOSUS REPAIR | 1 0.01 81.89 PATHOGEN RESISTANCE | 1 0.01 81.90 PELVIC VENOUS THROMBOSIS | 2 0.02 81.92 PEMPHIGOID | 1 0.01 81.93 PEMPHIGUS | 1 0.01 81.94 PEPTIC ULCER HAEMORRHAGE | 1 0.01 81.95 PERCUTANEOUS CORONARY INTERVENTION | 6 0.06 82.01 PERIARTHRITIS | 1 0.01 82.02 PERICARDITIS | 3 0.03 82.05 PERINEAL ABSCESS | 1 0.01 82.06 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE | 1 0.01 82.07 PERIPHERAL BLOOD STEM CELL APHERESIS | 1 0.01 82.08 PERIPHERAL ISCHAEMIA | 3 0.03 82.11 PERIPHERAL VASCULAR DISORDER | 1 0.01 82.12 PERITONITIS | 1 0.01 82.13 PETIT MAL EPILEPSY | 4 0.04 82.17 PHARYNGEAL CANCER STAGE UNSPECIFIED | 5 0.05 82.22 PHARYNGITIS | 7 0.07 82.29 PHARYNGITIS STREPTOCOCCAL | 4 0.04 82.33 PHARYNGOLARYNGEAL PAIN | 10 0.10 82.43 PHLEBITIS | 6 0.06 82.49 PHLEBITIS SUPERFICIAL | 2 0.02 82.51 PITUITARY TUMOUR | 1 0.01 82.52 PITUITARY TUMOUR REMOVAL | 1 0.01 82.53 PLASMACYTOMA | 1 0.01 82.54 PLATELET AGGREGATION INHIBITION | 1 0.01 82.55 PLATELET COUNT DECREASED | 1 0.01 82.56 PNEUMOCOCCAL INFECTION | 1 0.01 82.57 PNEUMOCYSTIS JIROVECI PNEUMONIA | 4 0.04 82.61 PNEUMONIA | 29 0.29 82.90 PNEUMONIA BACTERIAL | 3 0.03 82.93 PNEUMONIA STAPHYLOCOCCAL | 2 0.02 82.95 PNEUMONIA STREPTOCOCCAL | 1 0.01 82.96 POLLAKIURIA | 3 0.03 82.99 POLYARTHRITIS | 8 0.08 83.07 POLYCYSTIC OVARIES | 1 0.01 83.08 POLYCYTHAEMIA | 2 0.02 83.10 POLYMYALGIA RHEUMATICA | 1 0.01 83.11 POLYMYOSITIS | 2 0.02 83.13 POLYNEUROPATHY | 1 0.01 83.14 POLYP COLORECTAL | 1 0.01 83.15 PORPHYRIA | 2 0.02 83.17 POST HERPETIC NEURALGIA | 2 0.02 83.19 POST PROCEDURAL HAEMORRHAGE | 2 0.02 83.21 POST-TRAUMATIC STRESS DISORDER | 2 0.02 83.23 POSTOPERATIVE ANALGESIA | 10 0.10 83.33 POSTOPERATIVE CARE | 2 0.02 83.35 POSTOPERATIVE WOUND INFECTION | 4 0.04 83.39 POSTPARTUM DEPRESSION | 1 0.01 83.40 PRADER-WILLI SYNDROME | 1 0.01 83.41 PRE-ECLAMPSIA | 1 0.01 83.42 PREGNANCY | 1 0.01 83.43 PREMATURE LABOUR | 2 0.02 83.45 PREMEDICATION | 54 0.54 83.99 PRENATAL CARE | 1 0.01 84.00 PREOPERATIVE CARE | 4 0.04 84.04 PROCEDURAL PAIN | 6 0.06 84.10 PRODUCTIVE COUGH | 2 0.02 84.12 PROGERIA | 1 0.01 84.13 PROMOTION OF WOUND HEALING | 1 0.01 84.14 PROPHYLAXIS | 84 0.84 84.98 PROPHYLAXIS AGAINST DEHYDRATION | 1 0.01 84.99 PROPHYLAXIS AGAINST GASTROINTESTINAL .. | 7 0.07 85.06 PROPHYLAXIS AGAINST HIV INFECTION | 6 0.06 85.12 PROPHYLAXIS AGAINST MOTION SICKNESS | 1 0.01 85.13 PROPHYLAXIS AGAINST TRANSPLANT REJECT.. | 63 0.63 85.76 PROPHYLAXIS OF NAUSEA AND VOMITING | 14 0.14 85.90 PROSTATE CANCER | 47 0.47 86.37 PROSTATE CANCER METASTATIC | 4 0.04 86.41 PROSTATE EXAMINATION ABNORMAL | 1 0.01 86.42 PROSTATISM | 1 0.01 86.43 PROTEIN TOTAL | 1 0.01 86.44 PROTEINURIA | 1 0.01 86.45 PRURITUS | 2 0.02 86.47 PSEUDOMONAL BACTERAEMIA | 1 0.01 86.48 PSORIASIS | 34 0.34 86.82 PSORIATIC ARTHROPATHY | 28 0.28 87.10 PSYCHIATRIC SYMPTOM | 1 0.01 87.11 PSYCHOMOTOR HYPERACTIVITY | 1 0.01 87.12 PSYCHOTIC DISORDER | 25 0.25 87.37 PULMONARY EMBOLISM | 4 0.04 87.41 PULMONARY FIBROSIS | 2 0.02 87.43 PULMONARY HYPERTENSION | 21 0.21 87.64 PULMONARY OEDEMA | 1 0.01 87.65 PULMONARY TUBERCULOSIS | 8 0.08 87.73 PYELONEPHRITIS | 2 0.02 87.75 PYODERMA | 1 0.01 87.76 PYREXIA | 24 0.24 88.00 RADIOTHERAPY TO BONE | 1 0.01 88.01 RASH | 5 0.05 88.06 RASH PRURITIC | 2 0.02 88.08 RECTAL CANCER | 7 0.07 88.15 RECTAL CANCER METASTATIC | 2 0.02 88.17 REFLUX OESOPHAGITIS | 13 0.13 88.30 RELAPSING-REMITTING MULTIPLE SCLEROSIS | 12 0.12 88.42 RENAL ARTERY STENT PLACEMENT | 1 0.01 88.43 RENAL CANCER METASTATIC | 2 0.02 88.45 RENAL CELL CARCINOMA STAGE UNSPECIFIED | 40 0.40 88.85 RENAL CYST | 1 0.01 88.86 RENAL DISORDER | 1 0.01 88.87 RENAL FAILURE | 3 0.03 88.90 RENAL FAILURE CHRONIC | 26 0.26 89.16 RENAL IMPAIRMENT | 2 0.02 89.18 RENAL OSTEODYSTROPHY | 1 0.01 89.19 RENAL TRANSPLANT | 78 0.78 89.97 RESORPTION BONE INCREASED | 1 0.01 89.98 RESPIRATORY DISORDER | 6 0.06 90.04 RESPIRATORY FAILURE | 2 0.02 90.06 RESPIRATORY SYNCYTIAL VIRUS INFECTION | 2 0.02 90.08 RESPIRATORY THERAPY | 2 0.02 90.10 RESPIRATORY TRACT INFECTION | 3 0.03 90.13 RESTLESS LEGS SYNDROME | 10 0.10 90.23 RESTLESSNESS | 4 0.04 90.27 RETINAL OEDEMA | 4 0.04 90.31 RETINOBLASTOMA | 8 0.08 90.39 RETINOBLASTOMA BILATERAL | 8 0.08 90.47 RHEUMATIC HEART DISEASE | 1 0.01 90.48 RHEUMATOID ARTHRITIS | 372 3.72 94.20 RHINITIS | 3 0.03 94.23 RHINITIS ALLERGIC | 9 0.09 94.32 ROSACEA | 3 0.03 94.35 ROTATOR CUFF SYNDROME | 1 0.01 94.36 ROUTINE HEALTH MAINTENANCE | 1 0.01 94.37 SALPINGOPLASTY | 1 0.01 94.38 SARCOIDOSIS | 1 0.01 94.39 SARCOMA | 1 0.01 94.40 SCAN | 1 0.01 94.41 SCAN MYOCARDIAL PERFUSION | 3 0.03 94.44 SCHIZOAFFECTIVE DISORDER | 8 0.08 94.52 SCHIZOPHRENIA | 48 0.48 95.00 SCHIZOPHRENIA, PARANOID TYPE | 6 0.06 95.06 SCIATICA | 3 0.03 95.09 SCINTIGRAPHY | 1 0.01 95.10 SCOLIOSIS | 1 0.01 95.11 SEASONAL AFFECTIVE DISORDER | 1 0.01 95.12 SEASONAL ALLERGY | 10 0.10 95.22 SEBORRHOEIC DERMATITIS | 1 0.01 95.23 SECONDARY PROGRESSIVE MULTIPLE SCLERO.. | 3 0.03 95.26 SEDATION | 9 0.09 95.35 SEDATIVE THERAPY | 4 0.04 95.39 SELF-MEDICATION | 1 0.01 95.40 SENSITIVITY OF TEETH | 1 0.01 95.41 SENSORY DISTURBANCE | 5 0.05 95.46 SEPSIS | 5 0.05 95.51 SEPTIC SHOCK | 1 0.01 95.52 SICCA SYNDROME | 1 0.01 95.53 SIMPLE PARTIAL SEIZURES | 2 0.02 95.55 SINUS DISORDER | 2 0.02 95.57 SINUSITIS | 30 0.30 95.87 SKIN GRAFT | 1 0.01 95.88 SKIN INFECTION | 1 0.01 95.89 SKIN LESION | 2 0.02 95.91 SKIN MACERATION | 1 0.01 95.92 SKIN WRINKLING | 1 0.01 95.93 SLEEP DISORDER | 25 0.25 96.18 SLEEP DISORDER DUE TO GENERAL MEDICAL.. | 1 0.01 96.19 SLEEP DISORDER THERAPY | 1 0.01 96.20 SMALL CELL CARCINOMA | 1 0.01 96.21 SMALL CELL LUNG CANCER METASTATIC | 2 0.02 96.23 SMALL CELL LUNG CANCER STAGE UNSPECIF.. | 7 0.07 96.30 SMOKING CESSATION THERAPY | 21 0.21 96.51 SOFT TISSUE INFECTION | 1 0.01 96.52 SOMNOLENCE | 3 0.03 96.55 SPINA BIFIDA | 1 0.01 96.56 SPINAL ANAESTHESIA | 4 0.04 96.60 SPINAL COLUMN STENOSIS | 2 0.02 96.62 SPINAL COMPRESSION FRACTURE | 1 0.01 96.63 SPINAL OPERATION | 1 0.01 96.64 SPONDYLITIS | 1 0.01 96.65 SPONDYLOARTHROPATHY | 1 0.01 96.66 SPONDYLOLISTHESIS | 6 0.06 96.72 SQUAMOUS CELL CARCINOMA | 25 0.25 96.97 STAPHYLOCOCCAL INFECTION | 5 0.05 97.02 STASIS DERMATITIS | 1 0.01 97.03 STATUS EPILEPTICUS | 1 0.01 97.04 STEM CELL TRANSPLANT | 16 0.16 97.20 STENOTROPHOMONAS INFECTION | 1 0.01 97.21 STENT PLACEMENT | 3 0.03 97.24 STOMACH DISCOMFORT | 4 0.04 97.28 STOMATITIS | 3 0.03 97.31 STREPTOCOCCAL INFECTION | 2 0.02 97.33 STRESS | 9 0.09 97.42 SUBCUTANEOUS ABSCESS | 2 0.02 97.44 SUBDURAL HAEMORRHAGE | 1 0.01 97.45 SUICIDE ATTEMPT | 11 0.11 97.56 SUPRAVENTRICULAR TACHYCARDIA | 1 0.01 97.57 SURGERY | 3 0.03 97.60 SWEAT GLAND TUMOUR | 1 0.01 97.61 SWELLING | 1 0.01 97.62 SYNCOPE | 1 0.01 97.63 SYNOVIAL SARCOMA | 1 0.01 97.64 SYSTEMIC LUPUS ERYTHEMATOSUS | 12 0.12 97.76 SYSTEMIC MYCOSIS | 2 0.02 97.78 TACHYARRHYTHMIA | 2 0.02 97.80 TACHYCARDIA | 3 0.03 97.83 TEMPORAL LOBE EPILEPSY | 4 0.04 97.87 TENSION HEADACHE | 2 0.02 97.89 TESTICULAR CANCER METASTATIC | 1 0.01 97.90 TESTICULAR NEOPLASM | 3 0.03 97.93 THALASSAEMIA | 1 0.01 97.94 THORACIC HAEMORRHAGE | 1 0.01 97.95 THROMBECTOMY | 1 0.01 97.96 THROMBOPHLEBITIS | 1 0.01 97.97 THROMBOSIS | 2 0.02 97.99 THROMBOSIS PROPHYLAXIS | 25 0.25 98.24 THROMBOTIC STROKE | 1 0.01 98.25 THYROID DISORDER | 2 0.02 98.27 THYROID MASS | 1 0.01 98.28 THYROID NEOPLASM | 1 0.01 98.29 THYROIDECTOMY | 3 0.03 98.32 TIC | 1 0.01 98.33 TINEA INFECTION | 1 0.01 98.34 TINEA PEDIS | 4 0.04 98.38 TOCOLYSIS | 1 0.01 98.39 TONGUE NEOPLASM MALIGNANT STAGE UNSPE.. | 2 0.02 98.41 TONSIL CANCER | 4 0.04 98.45 TONSILLITIS | 6 0.06 98.51 TOOTH ABSCESS | 4 0.04 98.55 TOOTH DISORDER | 1 0.01 98.56 TOOTH EXTRACTION | 4 0.04 98.60 TOOTHACHE | 1 0.01 98.61 TORSADE DE POINTES | 4 0.04 98.65 TORTICOLLIS | 1 0.01 98.66 TOURETTE'S DISORDER | 1 0.01 98.67 TOXOPLASMOSIS | 4 0.04 98.71 TRACHEAL CANCER | 1 0.01 98.72 TRACHEAL OPERATION | 1 0.01 98.73 TRACHEOBRONCHITIS | 1 0.01 98.74 TRANSITIONAL CELL CARCINOMA | 1 0.01 98.75 TRANSPLANT | 4 0.04 98.79 TRANSPLANT REJECTION | 1 0.01 98.80 TRAUMATIC BRAIN INJURY | 1 0.01 98.81 TREMOR | 2 0.02 98.83 TRIGEMINAL NEURALGIA | 7 0.07 98.90 TUBERCULIN TEST | 1 0.01 98.91 TUBERCULOSIS | 4 0.04 98.95 TUBERCULOSIS SKIN TEST POSITIVE | 1 0.01 98.96 TURNER'S SYNDROME | 1 0.01 98.97 TYPE IIA HYPERLIPIDAEMIA | 5 0.05 99.02 ULCER | 3 0.03 99.05 ULCER HAEMORRHAGE | 1 0.01 99.06 ULTRASOUND SCAN | 1 0.01 99.07 UNEVALUABLE EVENT | 1 0.01 99.08 UPPER RESPIRATORY TRACT INFECTION | 8 0.08 99.16 UPPER RESPIRATORY TRACT INFLAMMATION | 5 0.05 99.21 URETERAL DISORDER | 1 0.01 99.22 URETHRAL CANCER | 5 0.05 99.27 URGE INCONTINENCE | 1 0.01 99.28 URINARY INCONTINENCE | 2 0.02 99.30 URINARY TRACT INFECTION | 11 0.11 99.41 UROSEPSIS | 1 0.01 99.42 URTICARIA | 5 0.05 99.47 UTERINE HAEMORRHAGE | 1 0.01 99.48 UTERINE LEIOMYOMA | 1 0.01 99.49 VAGINITIS BACTERIAL | 1 0.01 99.50 VARICELLA | 1 0.01 99.51 VASCULITIS | 2 0.02 99.53 VENOUS INSUFFICIENCY | 2 0.02 99.55 VENTRICULAR ASSIST DEVICE INSERTION | 1 0.01 99.56 VENTRICULAR EXTRASYSTOLES | 2 0.02 99.58 VENTRICULAR TACHYCARDIA | 2 0.02 99.60 VERTIGO | 1 0.01 99.61 VITAMIN B6 DEFICIENCY | 1 0.01 99.62 VITAMIN SUPPLEMENTATION | 6 0.06 99.68 VOMITING | 10 0.10 99.78 VULVOVAGINAL DRYNESS | 1 0.01 99.79 WALDENSTROM'S MACROGLOBULINAEMIA | 2 0.02 99.81 WEGENER'S GRANULOMATOSIS | 2 0.02 99.83 WEIGHT CONTROL | 2 0.02 99.85 WEIGHT DECREASED | 1 0.01 99.86 WHEEZING | 2 0.02 99.88 WHITE BLOOD CELL COUNT INCREASED | 3 0.03 99.91 WOUND | 5 0.05 99.96 WOUND COMPLICATION | 2 0.02 99.98 WOUND INFECTION | 2 0.02 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 18 Dec 2015